[1]
|
洪望龙, 郑淼淼, 马国强, 等. 瑞戈非尼治疗经索拉非尼治疗失败后的肝细胞癌的经济性[J]. 中国药房, 2023, 34(8): 968-973.
|
[2]
|
刘思莹, 徐丹, 张玲, 等. 基于科学知识图谱的五味子研究进展与前沿分析[J]. 中国中医药图书情报杂志, 2023, 47(3): 95-102.
|
[3]
|
Chen, Z. and Ye, S.Y. (2022) Research Progress on Antiviral Constituents in Traditional Chinese Medicines and Their Mechanisms of Action. Pharmaceutical Biology, 60, 1063-1076. https://doi.org/10.1080/13880209.2022.2074053
|
[4]
|
Feng, F., Pan, L., Wu, J., Liu, M., He, L., Yang, L. and Zhou, W. (2022) Schisantherin A Inhibits Cell Proliferation by Regulating Glucose Metabolism Pathway in Hepatocellular Carcinoma. Frontiers in Pharmacology, 13, Article ID: 1019486.
https://doi.org/10.3389/fphar.2022.1019486
|
[5]
|
付亚东, 陈佳美, 刘伟, 等. 五味子酯甲对肝脏药物代谢酶的调节及药理作用的研究进展[J]. 中药新药与临床药理, 2020, 31(6): 741-748. https://doi.org/10.19378/j.issn.1003-9783.2020.06.019
|
[6]
|
Xu, K., et al. (2010) Schisantherin A Exhibits Anti-Inflammatory Properties by Down-Regulating NF-κB and MAPK Signaling Pathways in Lipopolysaccharide-Treated RAW 264.7 Cells. Inflammation, 33, 126-136.
https://doi.org/10.1007/s10753-009-9166-7
|
[7]
|
Costa, R., Han, H.S. and Gradishar, W.J. (2018) Targeting the PI3K/AKT/mTOR Pathway in Triple-Negative Breast Cancer: A Review. Breast Cancer Research and Treatment, 169, 397-406. https://doi.org/10.1007/s10549-018-4697-y
|
[8]
|
Llovet, J.M., Peña, C.E., Lathia, C.D., Shan, M., Meinhardt, G., Bruix, J. and SHARP Investigators Study Group (2012) Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma. Clinical Cancer Research, 18, 2290-2300. https://doi.org/10.1158/1078-0432.CCR-11-2175
|
[9]
|
陈翔, 温迪光, 游逾, 等. 铁死亡在索拉非尼治疗肝癌中的作用及机制[J]. 临床肝胆病杂志, 2019, 35(10): 2316-2319.
|
[10]
|
杨蕙华, 陈大红, 刁文婧, 等. G6PD调控PI3K/Akt信号通路诱导肝癌细胞索拉非尼耐药的机制研究[J]. 中国药房, 2022, 33(19): 2338-2342.
|
[11]
|
杜若昕, 郭欣燕, 张伟, 等. 肝细胞癌中索拉非尼耐药性机制的研究进展[J]. 河北医科大学学报, 2022, 43(9): 1091-1095.
|
[12]
|
谭晖, 王吉昌, 董丹凤, 等. 五味子酯甲通过抑制CCAT1和PI3K-AKT信号通路抑制肺癌细胞的迁移和侵袭[J]. 世界中医药, 2021, 16(13): 1966-1971.
|
[13]
|
张吉超, 邹磊, 李道堂. 肺癌肝转移治疗的研究进展[J]. 中国现代普通外科进展, 2014, 17(3): 246-248.
|
[14]
|
Ying, X., Ma, N., Zhang, X., Guo, H., Liu, Y., Chen, B., Zhao, S., et al. (2021) Research Progress on the Molecular Mechanisms of Hepatic Metastasis in Lung Cancer: A Narrative Review. Annals of Palliative Medicine, 10, 4806-4822.
https://doi.org/10.21037/apm-20-1675
|
[15]
|
Yin, L., Liu, X., Shao, X., Feng, T., Xu, J., Wang, Q. and Hua, S. (2021) The Role of Exosomes in Lung Cancer Metastasis and Clinical Applications: An Updated Review. Journal of Translational Medicine, 19, Article No. 312.
https://doi.org/10.1186/s12967-021-02985-1
|
[16]
|
Lin, Q., Ling, Y.B., Chen, J.W., et al. (2018) Circular RNA circCDK13 Suppresses Cell Proliferation, Migration and Invasion by Modulating the JAK/STAT and PI3K/Akt Pathways in Liver Cancer. International Journal of Oncology, 53, 246-256. https://doi.org/10.3892/ijo.2018.4371
|
[17]
|
Cao, B., Liu, C. and Yang, G. (2018) RETRACTED: Down-Regulation of lncRNA ADAMTS9-AS2 Contributes to Gastric Cancer Development via Activation of PI3K/Akt Pathway. Biomedicine & Pharmacotherapy, 107, 185-193.
https://doi.org/10.1016/j.biopha.2018.06.146
|
[18]
|
Wang, S., Lei, Y., Cai, Z., et al. (2018) Girdin Regulates the Proliferation and Apoptosis of Pancreatic Cancer Cells via the PI3K/Akt Signalling Pathway. Oncology Reports, 40, 599-608. https://doi.org/10.3892/or.2018.6469
|
[19]
|
Yao, H., Su, S., Xia, D., et al. (2018) F-Box and Leucine-Rich Repeat Protein 5 Promotes Colon Cancer Progression by Modulating PTEN/PI3K/Akt Signaling Pathway. Biomedicine & Pharmacotherapy, 107, 1712-1719.
https://doi.org/10.1016/j.biopha.2018.08.119
|
[20]
|
Fujita, T., Washio, K., Takabatake, D., et al. (2005) Proteasome Inhibitors Can Alter the Signaling Pathways and Attenuate the P-Glycoprotein-Mediated Multidrug Resistance. International Journal of Cancer, 117, 670-682.
https://doi.org/10.1002/ijc.21063
|
[21]
|
Shinoda, C., et al. (2005) Doxorubicin Induces Expression of Multidrug Resistance-Associated Protein 1 in Human Small Cell Lung Cancer Cell Lines by the c-Jun N-Terminal Kinase Pathway. International Journal of Cancer, 117, 21-31. https://doi.org/10.1002/ijc.21094
|
[22]
|
小燕, 蔡晓军, 类建翔, 等. PI-3K/Akt抑制剂LY294002对卵巢癌细胞A2780/Taxol多药耐药性的逆转作用[J]. 癌症, 2008, 27(4): 343-347.
|
[23]
|
Choi, B.H., Kim, C.G., Lim, Y., et al. (2008) Curcumin Down-Regulates the Multidrug-Resistance mdr1b Gene by Inhibiting the PI3K/Akt/NF Kappa B Pathway. Cancer Letters, 259, 111-118.
https://doi.org/10.1016/j.canlet.2007.10.003
|
[24]
|
张劲远, 张银旭, 张俊华. PI3K-Akt信号通路对人大肠癌HCT-8/FU耐药细胞P-GP表达和耐药性的影响[J]. 东南大学学报院(医学版), 2013, 32(2): 169-172.
|
[25]
|
刘传铃, 王佳贺. 中药抗耐药铜绿假单胞菌机制的研究进展[J]. 中国医药导报, 2019, 16(3): 40-43.
|
[26]
|
李如佳, 戴园园, 覃春, 等. 中西医结合根治耐药幽门螺杆菌的方法分析[J]. 中华临床医师杂志(电子版), 2021, 15(9): 716-720.
|